Santhera Pharmaceuticals Holding AG/€SANN
05:30
09:10
12:45
16:25
20:00
1D1W1MYTD1Y5YMAX
About Santhera Pharmaceuticals Holding AG
Ticker
€SANN
Sector
Primary listing
XSWX
Industry
Biotechnology
Headquarters
Pratteln, Switzerland
Employees
79
Website
SANN Metrics
BasicAdvanced
€206M
-
-€3.97
-0.39
-
Price and volume
Market cap
€206M
Beta
-0.39
52-week high
€18.80
52-week low
€7.71
Average daily volume
25K
Financial strength
Current ratio
1.643
Quick ratio
1.188
Long term debt to equity
121.558
Total debt to equity
146.653
Interest coverage (TTM)
-4.26%
Profitability
EBITDA (TTM)
-30.113
Gross margin (TTM)
60.29%
Net profit margin (TTM)
-107.30%
Operating margin (TTM)
-84.75%
Effective tax rate (TTM)
-0.75%
Revenue per employee (TTM)
€537,870
Management effectiveness
Return on assets (TTM)
-15.81%
Return on equity (TTM)
-95.79%
Valuation
Price to revenue (TTM)
4.332
Price to book
6.88
Price to tangible book (TTM)
-4.62
Price to free cash flow (TTM)
-4.75
Free cash flow yield (TTM)
-21.05%
Free cash flow per share (TTM)
-3.371
Growth
Revenue change (TTM)
-62.17%
Earnings per share change (TTM)
-173.65%
3-year revenue growth (CAGR)
190.54%
10-year revenue growth (CAGR)
31.19%
3-year earnings per share growth (CAGR)
-38.99%
10-year earnings per share growth (CAGR)
-14.12%
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
Capital at risk
Upcoming events
No upcoming events
FAQs
What’s the current market cap for Santhera Pharmaceuticals Holding AG stock?
Santhera Pharmaceuticals Holding AG (SANN) has a market cap of €206M as of August 01, 2025.
What is the P/E ratio for Santhera Pharmaceuticals Holding AG stock?
The price to earnings (P/E) ratio for Santhera Pharmaceuticals Holding AG (SANN) stock is 0 as of August 01, 2025.
Does Santhera Pharmaceuticals Holding AG stock pay dividends?
No, Santhera Pharmaceuticals Holding AG (SANN) stock does not pay dividends to its shareholders as of August 01, 2025.
When is the next Santhera Pharmaceuticals Holding AG dividend payment date?
Santhera Pharmaceuticals Holding AG (SANN) stock does not pay dividends to its shareholders.
What is the beta indicator for Santhera Pharmaceuticals Holding AG?
Santhera Pharmaceuticals Holding AG (SANN) has a beta rating of -0.39. This means that it has an inverse relation to market volatility.